Inhibition of ecto-apyrase ecto-ATPase by pyridoxal phosphate-related compounds

Drug Development Research

Volumn 51, Issue 3, 2000, Pages 153-158

  Hoffmann, Carsten ^a   Heine, Petra ^b   Pradel, Gabi ^a   Kim, Yong Chul ^b   Jacobson, Kenneth A ^a   Zimmermann, Herbert ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

CD39; Ecto apyrase; Ecto ATPase; Enzyme inhibition; P2 receptors; PPADS

Indexed keywords

ADENOSINE TRIPHOSPHATASE; APYRASE; PURINE P2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL 5' PHOSPHATE 6 AZOPHENYL 2,4 DISULFONATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0034492841     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200011)51:3<153::AID-DDR3>3.0.CO;2-X     Document Type: Article

References (22)

1. Purinergic signalling: Pathophysiological roles
2. Reactive Red 2: A P2Y-selective purinoceptor antagonist and an inhibitor of ecto-nuceleotidase
3. P2-purinoceptor antagonists. I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates
4. P2-purinoceptor antagonists. III. Blockade of P2-purinoceptor sub-types and ecto-nucleotidases by compounds related to suramin
5. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: Functional consequences in rat vas deferens
6. Nomenclature and classification of purinoceptors: A report from the IUPHAR subcommittee
7. Substitution of His59 converts CD39 into an ADPase in a quartery structure dependent manner
8. Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells
9. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors
10. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain
11. Synthesis and structure-activity relationships of pyridoxal-6-arylazo-5′-phosphate and phosphonate derivatives as P2 receptor antagonists
12. Structure activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors
13. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses
14. Nucleotide receptors
15. Receptors for purines and pyrimidines
16. Control of cell membrane ecto-ATPase by oligomerization state: Intermolecular cross-linking modulates ATPase activity
17. P2-receptor antagonists. IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to Reactive Blue 2
18. The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure
19. P2-purinoceptor antagonists. II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue
20. Extracellular purine metabolism
21. Two novel families of ecto-nucleotidases: Molecular structures, catalytic properties, and a search for function
22. Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface